Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID)
PHASE3
Primary Objective:
This study aimed to demonstrate the efficacy of dupilum...
Status
Completed
Location
California Allergy and Asthma Medical Group, Inc. Site Number : 8400019
Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)
PHASE3
Primary Objective:
To demonstrate the efficacy of dupilumab in adult and a...
Status
Completed
Location
Allergy and Asthma Medical Group and Research Center-Site Number:8400001